TransEnterix Scores FDA Approval for Robotically-Assisted Surgical Device

The FDA granted 510(k) marketing clearance to TransEnterix Surgical for its robotically-assisted surgical device for facilitating minimally invasive surgery.

The Senhance system enables surgeons to accurately control laparoscopic instruments with three separate robotic arms. Surgeons can also use the system for 3-D visualization of the surgical field.

The system provides force feedback for assessing the stiffness of tissue and eye-tracking for accurately controlling the robotic arms.